Evidence map›Paper›PMID 32791542›Full record

ArticleHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme2020

Targeted RNAseq of Formalin-Fixed Paraffin-Embedded Tissue to Differentiate Among Benign and Malignant Adrenal Cortical Tumors.

Samuel W Plaska, Chia-Jen Liu, Jung Soo Lim, Juilee Rege, Nolan R Bick, Antonio M Lerario, Gary D Hammer, Thomas J Giordano, Tobias Else, Scott A Tomlins and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Samuel W PlaskaDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.ORCID 0000-0001-5128-6262
Chia-Jen LiuMichigan Center for Translational Pathology, Ann Arbor, Michigan, USA.
Jung Soo LimDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Juilee RegeDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Nolan R BickDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Antonio M LerarioDepartment of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Gary D HammerDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Thomas J GiordanoDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Tobias ElseDepartment of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Scott A TomlinsDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
William E RaineyDepartment of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Aaron M UdagerMichigan Center for Translational Pathology, Ann Arbor, Michigan, USA.
University of Michigan · USYonsei University · KR

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
Adrenal Origins of Aldosterone ExcessR01DK106618 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI William E Rainey, Aaron Mark Udager · 2016 to 2026
$6.0M
NCI NIH HHS P30 CA046592NIDDK NIH HHS R01 DK106618R01 DK106618 Health/National Institute of Diabetes and Digestive and Kidney DiseasesW81XWH-19-1-0528 G.D.H. is supported by the Department of Defense Congressionally Directed Medical Research ProgramsW81XWH-19-1-0623 G.D.H. is supported by the Department of Defense Congressionally Directed Medical Research Programs
6 · The paper itself

Abstract

Lack of routine fresh or frozen tissue is a barrier to widespread transcriptomic analysis of adrenal cortical tumors and an impediment to translational research in endocrinology and endocrine oncology. Our group has previously pioneered the use of targeted amplicon-based next-generation sequencing for archival formalin-fixed paraffin-embedded (FFPE) adrenal tissue specimens to characterize the spectrum of somatic mutations in various forms of primary aldosteronism. Herein, we developed and validated a novel 194-amplicon targeted next-generation RNA sequencing (RNAseq) assay for transcriptomic analysis of adrenal tumors using clinical-grade FFPE specimens. Targeted RNAseq-derived expression values for 27 adrenal cortical tumors, including aldosterone-producing adenomas (APA; n=8), cortisol-producing adenomas (CPA; n=11), and adrenal cortical carcinomas (ACC; n=8), highlighted known differentially-expressed genes (DEGs; i. e.,

Indexed as

TranscriptomeAdrenal Cortex NeoplasmsAdultAgedAged, 80 and overBiomarkers, TumorCohort StudiesDiagnosis, DifferentialFemaleFollow-Up StudiesFormaldehydeGene Expression Regulation, NeoplasticHumansMaleMiddle AgedParaffin EmbeddingBiomarkers, TumorFormaldehyde

Identifiers

PMID32791542
PMCPMC7880170
OpenAlexW3049521166

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.